Home/Filings/4/0001209191-17-052308
4//SEC Filing

GRINT PAUL C 4

Accession 0001209191-17-052308

CIK 0000921114other

Filed

Sep 10, 8:00 PM ET

Accepted

Sep 11, 8:17 PM ET

Size

7.9 KB

Accession

0001209191-17-052308

Insider Transaction Report

Form 4
Period: 2017-09-07
GRINT PAUL C
Director
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-09-07+190,076190,076 total
    Exercise: $0.91Exp: 2027-09-06Common Stock (190,076 underlying)
  • Award

    Stock Option (Right to Buy)

    2017-09-07+285,113285,113 total
    Exercise: $0.91Exp: 2027-09-06Common Stock (285,113 underlying)
Footnotes (2)
  • [F1]1/4th of the shares subject to the option vest on September 7, 2018. The remainder of the shares vest in equal monthly installments thereafter over the next three years.
  • [F2]100% of the shares subject to the stock option shall vest and become exercisable on September 5, 2027, subject to earlier vesting upon the satisfaction of performance criteria.

Issuer

AmpliPhi Biosciences Corp

CIK 0000921114

Entity typeother

Related Parties

1
  • filerCIK 0001236548

Filing Metadata

Form type
4
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 8:17 PM ET
Size
7.9 KB